Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP I: Ancrod in Acute Ischemic Stroke
NCT00141011Phase 3Terminated
- Sponsor
- Neurobiological Technologies, Inc.
- Start
- Sep 2005
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of ancrod in ischemic stroke, sponsored by Neurobiological Technologies, Inc.. Started Sep 2005; status: terminated.
02
Drugs
ancrod
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00141011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141011.